Related Experiment Video
Updated: Aug 4, 2025

09:51
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
934
Autophagy and cancer: Basic mechanisms and inhibitor development.
Yutaro Hama1,2, Yuta Ogasawara1, Nobuo N Noda1,2
1Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Cancer Science
|April 3, 2023
Summary
Autophagy, a cellular process, plays a dual role in cancer, acting as both a promoter and suppressor. This review explores its mechanisms, cancer roles, and emerging therapeutic strategies involving autophagy inhibitors.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Autophagy is a fundamental cellular process involving the lysosomal degradation of cytoplasmic components.
- It is crucial for maintaining cellular homeostasis by recycling biomolecules and organelles.
- Autophagy's involvement in cancer is complex and context-dependent, acting as both a tumor promoter and suppressor.
Purpose of the Study:
- To review the fundamental mechanisms of autophagy.
- To elucidate the multifaceted roles of autophagy in various cancer types and stages.
- To summarize current clinical trials and future directions for autophagy inhibitors in cancer therapy.
Main Methods:
- Literature review of autophagy mechanisms.
- Analysis of studies detailing autophagy's role in cancer progression and suppression.
- Compilation of data from clinical trials on autophagy inhibitors.
Main Results:
- Autophagy's function varies, promoting or suppressing cancer based on specific contexts.
- Existing clinical trials investigate autophagy inhibitors for cancer treatment.
- Development of targeted autophagy inhibitors is ongoing for enhanced efficacy.
Conclusions:
- Autophagy presents a complex therapeutic target in oncology.
- Targeted inhibition of autophagy holds promise for cancer treatment.
- Further research into specific autophagy inhibitors is crucial for clinical application.
Related Concept Videos
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Autophagy
4.4K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
The Intrinsic Apoptotic Pathway
6.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K

